Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
FIMM is seeking outstanding candidates for positions of FIMM-EMBL Group Leaders in Molecular Medicine This group leader search is for 2-3 early-stage group leaders with significant international
-
infrastructure data to model how government policy shapes cloud geography. The position can be tailored towards qualitative or quantitative work, depending on the researcher’s background. You will also contribute
-
technicians in designing and conducting molecular biology experiments. Writing own grant applications Skills, expertise and/or qualifications A PhD degree in any relevant field of life sciences Successfully
-
Researcher will be offered a full-time contract for the maximum duration of 4 years. There will be a trial period of six months at the beginning of employment. Position description The successful candidate
-
to join our interdisciplinary team advancing the frontiers of cancer research through single-cell and spatial omics technologies. About the position This position offers the opportunity to work at the
-
a Doctoral Researcher for experiments in swarming dynamics of living swimmers A 4-year Doctoral Researcher position is available in the Living, Fluid, & Soft Matter group of Prof. Matilda Backholm
-
Prostate Cancer UK. The position is for 3 years, and we hope that the candidate starts in autumn 2025. Background The research in Itkonen laboratory is focused on how the information embedded in the genome
-
within a multidisciplinary research environment spanning two Nordic countries, with active groups in Helsinki and Oslo. The position is open to applicants with a PhD degree in computational biology
-
The Faculty of Biological and Environmental Sciences and the laboratory of Dr. Suvi Kuivanen invites applications for the position of Doctoral researcher in zoonotic virology starting 1 August 2025
-
experience in wet-lab and computational techniques. This position is intended for an MSc-level graduate planning to pursue a PhD degree. In this project, we aim to profile AML cancer cells treated with drug